UF Health Jacksonville is actively enrolling patients in COVID-19 research studies to help researchers and clinicians understand and target treatment options for COVID-19.
Two of the studies are clinical trials looking at potential medications effective in treating patients with COVID-19. One study is looking at losartan, an antihypertensive medication, and a placebo. According to the press release, the trial specifically seeks to identify improvements in patients with COVID-19 who are experiencing respiratory failure.
“Our team of emergency medicine physicians engaged in COVID-19 studies exemplifies the spirit of our division and our commitment to contributing to the greater good of the medical community,” said Dr. Phyllis Hendry, the associate chair of emergency medicine research at UF Health Jacksonville. “Our entire research team and campus have worked tirelessly to bring COVID-19-related studies on board in a rapid manner. We could not do this without our research coordinators and the support of emergency medicine nursing leadership.”Learn more about UF Health Jacksonville to Start Five COVID-19 Research Projects.